Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Lilly delivers upbeat earnings forecast for 2013

New products will offset generic competition for Alimta, Zyprexa, Cymbalta and Evista

- PMLiVE

Sanofi enters vaccines partnership with Sutro

Will develop products for two undisclosed targets

- PMLiVE

Biogen submits haemophilia drug for US approval

Step forward for its partnership with Swedish Orphan Biovitrum

Building brand strength – Part 2

The Iconic Brands series to help you create your brand's unique DNA

- PMLiVE

Agneta Svedberg appointed COO at Zealand Pharma

Succeeds company co-founder John Hottel who retires

Pharma deals during December 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Pharma social media update – Twitter

AbbVie's Twitter debut is the perfect opportunity for a Digital Handbook update

- PMLiVE

Pfizer acquires spinal muscular atrophy research programme

Gains rights to drug candidate RG3039 in deal with Repligen that could be worth up to $70m

- PMLiVE

Nexavar shows promise in thyroid cancer

Potential new indication for Bayer/Onyx drug

- PMLiVE

Biogen Idec drops ALS drug dexpramipexole

Fails to achieve efficacy in phase III trial

- PMLiVE

Jayson Dallas to lead Roche in the UK

He takes over from John Melville who has retired

- PMLiVE

NICE set to approve Novartis eye drug Lucentis

Final draft guidance says treatment is cost-effective in diabetic macular oedema

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links